Neuroinflammation in Parkinson's disease: a target for neuroprotection?
EC Hirsch, S Hunot - The Lancet Neurology, 2009 - thelancet.com
Parkinson's disease is characterised by a slow and progressive degeneration of
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
[PDF][PDF] Neuroinflammation in Parkinson's disease: a target for neuroprotection?
EC Hirsch, S Hunot - Lancet Neurol, 2009 - Citeseer
Parkinson's disease is characterised by a slow and progressive degeneration of
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
[引用][C] NEUROINFLAMMATION IN PARKINSONS DISEASE: A TARGET FOR NEUROPROTECTION?
EC HIRSCH, S HUNOT - 2009 - sid.ir
[引用][C] Neuroinflammation in parkinson's disease: a target for neuroprotection?
H EC - Lancet Neurol, 2009 - cir.nii.ac.jp
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
EC Hirsch, S Hunot - The Lancet. Neurology, 2009 - pubmed.ncbi.nlm.nih.gov
Parkinson's disease is characterised by a slow and progressive degeneration of
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
Neuroinflammation in Parkinsons disease: a target for neuroprotection?
EC Hirsch, S Hunot - The Lancet Neurology, 2009 - elibrary.ru
Parkinson's disease is characterised by a slow and progressive degeneration of
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
EC Hirsch, S Hunot - The Lancet Neurology, 2009 - thelancet.com
Parkinson's disease is characterised by a slow and progressive degeneration of
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
EC Hirsch, S Hunot - The Lancet Neurology, 2009 - Elsevier
Parkinson's disease is characterised by a slow and progressive degeneration of
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
EC Hirsch, S Hunot - The Lancet Neurology, 2009 - infona.pl
Parkinson's disease is characterised by a slow and progressive degeneration of
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
EC Hirsch, S Hunot - The Lancet. Neurology, 2009 - europepmc.org
Parkinson's disease is characterised by a slow and progressive degeneration of
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …
dopaminergic neurons in the substantia nigra. Despite intensive research, the cause of the …